Compugen (CGEN) Net Income towards Common Stockholders (QoQ) (2009 - 2026)
Compugen (CGEN) Net Income towards Common Stockholders (QoQ) (2009 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Compugen | 215.59 Mn | 123.84 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -86.50% |
| Dec 31, 2025 | 922.39% |
| Sep 30, 2025 | 68.08% |
| Jun 30, 2025 | -403.61% |
| Mar 31, 2025 | 216.38% |
| Dec 31, 2024 | -159.48% |
| Sep 30, 2024 | 161.87% |
| Jun 30, 2024 | -328.94% |
| Mar 31, 2024 | -25.24% |
| Dec 31, 2023 | 198.59% |
| Sep 30, 2023 | 64.81% |
| Jun 30, 2023 | -400.65% |
| Mar 31, 2023 | 401.20% |
| Dec 31, 2022 | 73.68% |
| Sep 30, 2022 | -141.13% |
| Jun 30, 2022 | 394.17% |
| Mar 31, 2022 | -12.32% |
| Dec 31, 2021 | -5.74% |
| Sep 30, 2021 | 13.91% |
| Jun 30, 2021 | 4.12% |